Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.statnews.com/2023/11/11/heart-attack-stroke-obesity-wegovy-novo-nordisk-select/
0
0
Wegovy cuts risk of heart attacks in milestone cardiovascular trial - STAT
11/11/23 at 3:33pm
Organization
STAT
Author
Elaine Chen
Details
39 words
Summarize
Heart & Hypertension
Novo Nordisk
Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...